Literature DB >> 18322398

Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease.

Scott E Counts1, Bin He, Shaoli Che, Stephen D Ginsberg, Elliott J Mufson.   

Abstract

BACKGROUND: Fibers containing galanin (GAL) enlarge and hyperinnervate cholinergic basal forebrain (CBF) nucleus basalis (NB) neurons in late-stage Alzheimer's disease (AD), yet the physiological consequences of this phenomenon are unclear.
OBJECTIVE: To determine whether GAL hyperinnervation of cholinergic NB neurons modulates the expression of genes critical to cholinergic transmission [e.g. acetylcholine (ACh) metabolism and ACh receptors] in AD.
METHODS: Single-cell gene expression profiling was used to compare cholinergic mRNA levels in non-GAL-hyperinnervated NB neurons in tissue autopsied from cases classified as having no cognitive impairment (NCI) or late-stage AD (AD/GAL-) and in GAL-hyperinnervated (AD/GAL+) NB neurons from the same AD subjects.
RESULTS: AD/GAL+ cells displayed a significant upregulation in choline acetyltransferase (ChAT) mRNA expression compared to NCI and AD/GAL- cells.
CONCLUSION: GAL fiber hyperinnervation of cholinergic NB neurons upregulates the expression of ChAT, the synthetic enzyme for ACh, suggesting that GAL regulates the cholinergic tone of CBF neurons in AD. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322398      PMCID: PMC2826456          DOI: 10.1159/000113710

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  18 in total

1.  A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease.

Authors:  R Bowser; J H Kordower; E J Mufson
Journal:  Brain Pathol       Date:  1997-04       Impact factor: 6.508

2.  Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies.

Authors:  G Fisone; C F Wu; S Consolo; O Nordström; N Brynne; T Bartfai; T Melander; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.

Authors:  V Chan-Palay
Journal:  J Comp Neurol       Date:  1988-07-22       Impact factor: 3.215

4.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

5.  Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons.

Authors:  E J Mufson; M Bothwell; L B Hersh; J H Kordower
Journal:  J Comp Neurol       Date:  1989-07-08       Impact factor: 3.215

6.  Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome.

Authors:  E J Mufson; E Cochran; W Benzing; J H Kordower
Journal:  Dementia       Date:  1993 Sep-Oct

Review 7.  Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases.

Authors:  J Q Trojanowski; V M Lee
Journal:  FASEB J       Date:  1995-12       Impact factor: 5.191

8.  Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions.

Authors:  M P McDonald; L B Willard; G L Wenk; J N Crawley
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

9.  Amplification of RNA transcripts using terminal continuation.

Authors:  Shaoli Che; Stephen D Ginsberg
Journal:  Lab Invest       Date:  2004-01       Impact factor: 5.662

10.  Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.

Authors:  Scott E Counts; Bin He; Shaoli Che; Milos D Ikonomovic; Steven T DeKosky; Stephen D Ginsberg; Elliott J Mufson
Journal:  Arch Neurol       Date:  2007-12
View more
  22 in total

1.  Biological impact of low dose-rate simulated solar particle event radiation in vivo.

Authors:  P Y Chang; R Doppalapudi; J Bakke; A Wang; S Menda; Z Davis
Journal:  Radiat Environ Biophys       Date:  2010-05-16       Impact factor: 1.925

2.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

Review 3.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

4.  Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.

Authors:  Sunil Swami; Ronald A Cohen; John A Kairalla; Todd M Manini
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

Review 5.  Hippocampal plasticity during the progression of Alzheimer's disease.

Authors:  E J Mufson; L Mahady; D Waters; S E Counts; S E Perez; S T DeKosky; S D Ginsberg; M D Ikonomovic; S W Scheff; L I Binder
Journal:  Neuroscience       Date:  2015-03-12       Impact factor: 3.590

6.  Fronto-temporal galanin modulates impulse control.

Authors:  F Messanvi; A Perkins; J du Hoffmann; Y Chudasama
Journal:  Psychopharmacology (Berl)       Date:  2019-11-08       Impact factor: 4.530

7.  Local cholinergic-GABAergic circuitry within the basal forebrain is modulated by galanin.

Authors:  Joanne C Damborsky; Kathleen G Smith; Patricia Jensen; Jerrel L Yakel
Journal:  Brain Struct Funct       Date:  2016-08-05       Impact factor: 3.270

8.  Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis.

Authors:  Stephen D Ginsberg; Melissa J Alldred; Satya M Gunnam; Consuelo Schiroli; Sang Han Lee; Susan Morgello; Tracy Fischer
Journal:  Ann Neurol       Date:  2018-02-10       Impact factor: 10.422

9.  Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  FASEB J       Date:  2019-06-10       Impact factor: 5.191

10.  Unraveling the genes implicated in Alzheimer's disease.

Authors:  Mohan Giri; Abhilasha Shah; Bibhuti Upreti; Jayanti Chamling Rai
Journal:  Biomed Rep       Date:  2017-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.